Phosphorus Joins the Global Alliance for Genomics and Health

Phosphorus, a leading preventative genomics company, joins GA4GH in its mission to maximize the potential of genomic medicine through effective and responsible data sharing and utilization.

Beginning February 2022, Phosphorus will join the Global Alliance for Genomics and Health. GA4GH creates frameworks and standards enabling voluntary and secure sharing of genomic and precision medicine data. As the developer of GeneCompass™, the first holistic medical-grade genetic test available at a consumer price point, Phosphorus is committed to collaborative research and data sharing balanced with protective and transparent data management practices.

Phosphorus believes responsible, standardized data management is critical to ensuring public trust in handling of genomic information and strongly supports the efforts of GA4GH. The Phosphorus privacy practices and policies are fully explained on the company’s website and are designed to  allow consumers to take broad control over how their information is utilized.

GA4GH and Phosphorus also share a dedication to responsible genomics research that advances its utilization and clinical impact. The IRB-approved CARTOGRAPHTM study is an optional program that aims to understand how holistic genomics information discovered by GeneCompass affects individual health outcomes. Following the strictest research protocols, Phosphorus will also publish data on its website, preprint archives, and open-access peer-reviewed journals.

“We’re proud to join GA4GH to show our support for their leading efforts and to be part of the community helping to move towards best practices regarding clinical and genomic data protection and research” said Alex Bisignano, Founder and CEO of Phosphorus. “Membership signals our commitment to this worldwide effort to advance the utility of clinical genomics.”

“As a driver of genomic-based precision medicine, Phosphorus has an array of experience in the scientific, regulatory and technical aspects of clinical genomic testing. We look forward to contributing to GA4GH initiatives and working to further their efforts to create better understanding, clinical utility and protection of genomic data” said Malgorzata Jaremko, PhD, Co-Founder and SEVP of Clinical Laboratory and Molecular Diagnostics at Phosphorus.

For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybersecurity, go to

Related posts

Xaira Therapeutics announced its launch

Business Wire

Cardio Diagnostics Holdings Inc launches PrecisionCHD™

Business Wire

Genomics for Cancer Leader Personalis to Present on ImmunoID NeXT

Business Wire